[10] [22] Disease-modifying therapies commonly used in MS include: Injectable therapies : Interferon beta preparations (Avonex, Rebif, Betaseron) and glatiramer acetate (Copaxone) Oral agents : Fingolimod (Gilenya), dimethyl fumarate (Tecfidera), teriflunomide (Aubagio), siponimod (Mayzent), ozanimod (Zeposia), and cladribine (Mavenclad) Infusion therapies : Natalizumab (Tysabri), ocrelizumab (Ocrevus), alemtuzumab (Lemtrada) Subcutaneous injection : Ofatumumab (Kesimpta) No direct drug-drug interactions between tirzepatide and these DMTs have been identified in pharmacological studies
J Neurol 259(5):886894 Waisbourd M et al (2011) OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension
Grammy- and Emmy-winning singer-songwriter Brandi Carlile will deliver a rendition of America the Beautiful at Super Bowl LX
Lavie, C
Within this framework, healthcare professionals are advised to prescribe medications like Ozempic in alignment with the FDA-approved indications, to ensure a responsible and ethical utilization of the available supply
On the other hand, we have examined many patients who appear to have widespread pain and a global reduction of pain thresholds, associated with pronounced fatigue, low energy, and typically, a sleep disorder